Novo Nordisk ' s Stock Could Get Another Boost, Thanks to This Huge Development

Novo Nordisk (NYSE: NVO) has become one of the most valuable healthcare stocks in the world, largely due to a couple of exceptional drugs, Ozempic and Wegovy. While the former is a diabetes drug and the latter is approved for weight loss, consumers have been using both to help lose weight. And…#novonordisk #nvo #ozempicandwegovy #wegovyformedicare #cvshealth #kaiserpermanente #medicare #fda #wegovy #denmark
Source: Reuters: Health - Category: Consumer Health News Source Type: news